Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-12 · accession 0001415889-25-017270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-13 | 2025-06-12 | HALO | Snyder Mark Howard | SVP, CLO | F - Tax | $54.54 | -2,711 | 30.8K | -8% | -$147.9K |
| D | 2025-06-13 | 2025-06-12 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | +5,035 | 33.5K | +18% | $0 |
| D | 2025-06-13 | 2025-06-12 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | -5,035 | 15.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-12 | F | D | 2,711 | $54.54 | 30,813 | D | — | — | (F1) The reported disposition of 2,711 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 2 | Common | Common Stock | 2025-06-12 | M | A | 5,035 | $0.00 | 33,524 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-06-12 | M | D | 5,035 | $0.00 | 15,102 | D | $0.00 · — to — | 5,035 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |